Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.

Wednesday, 5th of December 2018 Print

Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.

Brandon D, Kimmel M, Kuriyakose SO, Kostanyan L, Mesaros N.

Vaccine. 2018 Oct 8;36(42):6325-6333.. Epub 2018 Sep 7.

https://www.ncbi.nlm.nih.gov/pubmed/30197282

24377569